These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38076358)

  • 1. Diabetes Mellitus and Poor Glycemic Control Negatively Impact Clinical Outcomes and Survival in Patients with Compensated Cirrhosis.
    Boonpiraks K; Bunyuen A; Dechphol P; Sanpawithayakul K; Siramolpiwat S
    J Clin Exp Hepatol; 2024; 14(1):101257. PubMed ID: 38076358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis.
    Siramolpiwat S; Kiattikunrat K; Soontararatpong R; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanun P; Issariyakulkarn N
    Scand J Gastroenterol; 2021 Oct; 56(10):1210-1219. PubMed ID: 34338110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis.
    Kwon JH; Lee SS; Yoon JS; Suk HI; Sung YS; Kim HS; Lee CM; Kim KM; Lee SJ; Kim SY
    Korean J Radiol; 2021 Dec; 22(12):1985-1995. PubMed ID: 34564961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis.
    Navadurong H; Thanapirom K; Wejnaruemarn S; Prasoppokakorn T; Chaiteerakij R; Komolmit P; Treeprasertsuk S
    World J Gastroenterol; 2023 Aug; 29(32):4873-4882. PubMed ID: 37701131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India.
    Shah AS; Amarapurkar DN
    J Clin Exp Hepatol; 2018 Mar; 8(1):50-57. PubMed ID: 29743797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality.
    Hundersmarck D; Groot OQ; Schuijt HJ; Hietbrink F; Leenen LPH; Heng M
    Clin Orthop Relat Res; 2022 Jun; 480(6):1077-1088. PubMed ID: 34978539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients.
    Hsiang JC; Gane EJ; Bai WW; Gerred SJ
    J Gastroenterol Hepatol; 2015 Mar; 30(3):591-9. PubMed ID: 25250942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
    Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
    Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
    Vilar-Gomez E; Calzadilla-Bertot L; Wong VW; Castellanos M; Aller-de la Fuente R; Eslam M; Wong GL; George J; Romero-Gomez M; Adams LA
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):136-145.e6. PubMed ID: 32389886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
    Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A
    J Gastroenterol; 2020 May; 55(5):533-542. PubMed ID: 31832759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.
    Paternostro R; Kapzan L; Mandorfer M; Schwarzer R; Benedikt S; Viveiros A; Bauer D; Ferlitsch M; Zoller H; Trauner M; Ferlitsch A
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1619-1627. PubMed ID: 31972057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of Complications in Cirrhosis.
    Premkumar M; Anand AC
    J Clin Exp Hepatol; 2022; 12(4):1150-1174. PubMed ID: 35814522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis.
    Dultz G; Seelhof M; Herrmann E; Welker MW; Friedrich-Rust M; Teuber G; Kronenberger B; von Wagner M; Vermehren J; Sarrazin C; Zeuzem S; Hofmann WP
    PLoS One; 2013; 8(8):e71262. PubMed ID: 23936497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study.
    Huo TI; Lui WY; Huang YH; Chau GY; Wu JC; Lee PC; Chang FY; Lee SD
    Am J Gastroenterol; 2003 Oct; 98(10):2293-8. PubMed ID: 14572582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study.
    Quintana JO; García-Compean D; González JA; Pérez JZ; González FJ; Espinosa LE; Hernández PL; Cabello ER; Villarreal ER; Rendón RF; Garza HM
    Ann Hepatol; 2011; 10(1):56-62. PubMed ID: 21301011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.